Wiley Bros. Aintree Capital, LLC Novo Nordisk A S Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 47,526 shares of NVO stock, worth $3.83 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
47,526
Previous 15,595
204.75%
Holding current value
$3.83 Million
Previous $2.23 Million
154.18%
% of portfolio
0.11%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,911Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.63 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.16 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.15 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.07 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$984 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $182B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...